X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (212) 212
female (121) 121
male (120) 120
adult (102) 102
arachnoiditis (94) 94
middle aged (87) 87
arachnoiditis - drug therapy (74) 74
clinical neurology (71) 71
index medicus (60) 60
adolescent (44) 44
injections, spinal (42) 42
magnetic resonance imaging (41) 41
aged (38) 38
surgery (37) 37
arachnoiditis - etiology (36) 36
meningitis (36) 36
arachnoiditis - chemically induced (28) 28
arachnoiditis - diagnosis (28) 28
arachnoiditis - complications (27) 27
child (27) 27
animals (26) 26
treatment outcome (24) 24
tuberculosis, meningeal - drug therapy (23) 23
chronic disease (21) 21
diagnosis (21) 21
neurosciences (21) 21
tuberculosis, meningeal - complications (20) 20
antitubercular agents - therapeutic use (19) 19
arachnoiditis - pathology (17) 17
management (17) 17
tuberculosis (17) 17
diagnosis, differential (16) 16
hydrocephalus (16) 16
arachnoiditis - surgery (15) 15
follow-up studies (15) 15
therapy (15) 15
complications and side effects (14) 14
care and treatment (13) 13
drug therapy, combination (13) 13
laminectomy (13) 13
myelography (13) 13
neurosurgery (13) 13
spinal arachnoiditis (13) 13
tuberculosis, meningeal - diagnosis (13) 13
hyaluronoglucosaminidase - therapeutic use (12) 12
medicine & public health (12) 12
pain (12) 12
prognosis (12) 12
syringomyelia (12) 12
time factors (12) 12
anesthesiology (11) 11
child, preschool (11) 11
medicine, general & internal (11) 11
meningitis - drug therapy (11) 11
methylprednisolone - administration & dosage (11) 11
amphotericin b - therapeutic use (10) 10
infant (10) 10
intervertebral disc displacement - drug therapy (10) 10
morphine - administration & dosage (10) 10
pediatrics (10) 10
research (10) 10
risk factors (10) 10
spinal cord - pathology (10) 10
spinal cord diseases - drug therapy (10) 10
tuberculous meningitis (10) 10
adhesive arachnoiditis (9) 9
arachnoiditis - therapy (9) 9
central-nervous-system (9) 9
dogs (9) 9
health aspects (9) 9
hydrocephalus - etiology (9) 9
injections (9) 9
neurology (9) 9
orthopedics (9) 9
retrospective studies (9) 9
spinal cord (9) 9
spine (9) 9
tomography, x-ray computed (9) 9
young adult (9) 9
acute disease (8) 8
adrenal cortex hormones - therapeutic use (8) 8
cerebrospinal-fluid (8) 8
chemotherapy (8) 8
methotrexate - administration & dosage (8) 8
methylprednisolone - adverse effects (8) 8
optic chiasm - pathology (8) 8
pain, intractable - drug therapy (8) 8
prednisone - therapeutic use (8) 8
radiography (8) 8
analgesics - therapeutic use (7) 7
anesthesia (7) 7
antifungal agents - therapeutic use (7) 7
arachnoiditis - physiopathology (7) 7
back pain - drug therapy (7) 7
central nervous system (7) 7
complications (7) 7
disease progression (7) 7
headache (7) 7
injections, epidural (7) 7
laminectomy - adverse effects (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 2017, Volume 64, Issue 3, pp. 275 - 283
Background. Cryptococcus can cause meningoencephalitis (CM) among previously healthy non-HIV adults. Spinal arachnoiditis is under-recognized, since diagnosis... 
Cryptococcus | Cauda equina/conus syndromes | Spinal arachnoiditis | Meningoencephalitis | Pulse corticosteroids | pulse corticosteroids | INFECTIOUS DISEASES | spinal arachnoiditis | SURROGATE END-POINTS | MICROBIAL PATHOGENESIS | DETERMINANTS | MICROBIOLOGY | IMMUNOLOGY | PROGRESSIVE MULTIPLE-SCLEROSIS | MENINGITIS | cauda equina/conus syndromes | meningoencephalitis | INFECTIOUS-DISEASES | ADJUNCTIVE DEXAMETHASONE | CLINICAL-TRIALS | DAMAGE-RESPONSE FRAMEWORK | OUTCOMES | Meningitis, Cryptococcal - drug therapy | Meningoencephalitis - cerebrospinal fluid | Methylprednisolone - therapeutic use | Arachnoiditis - microbiology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Infectious Encephalitis - complications | Male | Infectious Encephalitis - immunology | Methotrexate - therapeutic use | Arachnoiditis - drug therapy | Meningoencephalitis - immunology | Young Adult | CD4-CD8 Ratio | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Meningoencephalitis - drug therapy | Arachnoiditis - diagnostic imaging | Arachnoiditis - congenital | Infectious Encephalitis - cerebrospinal fluid | Magnetic Resonance Angiography | Arachnoiditis - immunology | Infectious Encephalitis - drug therapy | Pulse Therapy, Drug | Tacrolimus - therapeutic use | Meningoencephalitis - complications | Neurologic Examination | Biomarkers - cerebrospinal fluid | Meningitis, Cryptococcal - immunology | Meningitis, Cryptococcal - complications | Complications and side effects | Arachnoiditis | Central nervous system | Adults | Research | Diagnosis | Health aspects | Major | cauda equina | conus syndromes
Journal Article
American Journal of Tropical Medicine and Hygiene, ISSN 0002-9637, 2018, Volume 98, Issue 3, pp. 800 - 802
Journal Article
Journal Article
Expert Review of Anti-infective Therapy, ISSN 1478-7210, 09/2011, Volume 9, Issue 9, pp. 719 - 729
Tuberculous meningitis is primarily a disease of the meninges of brain and spinal cord along with adjacent brain parenchyma. The characteristic pathological... 
tuberculoma | Mycobacterium tuberculosis | arachnoiditis | meningitis | tuberculosis | suprasellar cistern | vision loss | optic nerve | MANAGEMENT | VISION | OPTOCHIASMATIC ARACHNOIDITIS | SEVERE PARADOXICAL REACTION | THALIDOMIDE | VISUAL-LOSS | INTRACRANIAL TUBERCULOMAS | GRANULOMA | THERAPY | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | Tuberculoma - physiopathology | Tuberculosis, Meningeal - physiopathology | Arachnoiditis - microbiology | Humans | Middle Aged | Arachnoiditis - physiopathology | Blindness - pathology | Child, Preschool | Male | Arachnoid - physiopathology | Arachnoiditis - drug therapy | Tuberculoma - pathology | Hydrocephalus - physiopathology | Tuberculosis, Meningeal - pathology | Blindness - drug therapy | Child | Tuberculosis, Meningeal - drug therapy | Arachnoiditis - pathology | Arachnoid - pathology | Magnetic Resonance Imaging | Blindness - microbiology | Tuberculosis, Meningeal - complications | Adolescent | Spinal Cord - physiopathology | Tuberculosis, Meningeal - microbiology | Optic Chiasm - pathology | Optic Chiasm - drug effects | Arachnoiditis - complications | Tuberculosis, Meningeal - diagnosis | Blindness - physiopathology | Hydrocephalus - pathology | Tuberculoma - complications | Mycobacterium tuberculosis - drug effects | Optic Chiasm - physiopathology | Spinal Cord - pathology | Spinal Cord - microbiology | Mycobacterium tuberculosis - physiology | Adult | Female | Optic Chiasm - microbiology | Arachnoid - microbiology | Arachnoiditis - diagnosis | Tuberculoma - diagnosis | Hydrocephalus - diagnosis | Tuberculoma - drug therapy | Blindness - diagnosis | Hydrocephalus - complications | Hydrocephalus - drug therapy | Hydrocephalus - microbiology | Blindness - complications | Aged | Tuberculoma - microbiology | Complications and side effects | Care and treatment | Arachnoiditis | Blindness | Meningitis | Diagnosis | Risk factors
Journal Article
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 03/2012, Volume 23, Issue 3, pp. 342 - 346
The prognosis of recurrent medulloblastoma is dismal, with a median survival of less than 1 year. Our patient was initially diagnosed with high-risk... 
Recurrence | Metronomic therapy | Antiangiogenic therapy | Medulloblastoma | Liposomal cytarabine | antiangiogenic therapy | SOLID TUMORS | FEASIBILITY | medulloblastoma | SAFETY | liposomal cytarabine | metronomic therapy | CHILDREN | recurrence | TRIAL | ONCOLOGY | PHARMACOLOGY & PHARMACY | HIGH-DOSE CHEMOTHERAPY | RADIOTHERAPY | LEUKEMIA | Injections, Spinal | Cerebellar Neoplasms - drug therapy | Liposomes - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Administration, Metronomic | Cytarabine - therapeutic use | Humans | Neoplasm Recurrence, Local - drug therapy | Etoposide - administration & dosage | Male | Treatment Outcome | Celecoxib | Thalidomide - administration & dosage | Cytarabine - administration & dosage | Angiogenesis Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Medulloblastoma - pathology | Adolescent | Angiogenesis Inhibitors - therapeutic use | Cerebellar Neoplasms - pathology | Medulloblastoma - drug therapy | Neutropenia - chemically induced | Sulfonamides - administration & dosage | cytarabine | Prognosis | Risk groups | Prophylaxis | Etoposide | Survival | Hearing loss | Quality of life | Side effects | Arachnoiditis | Thalidomide | Steroid hormones | Neutropenia
Journal Article
Journal Article
Journal Article